Invention Grant
![Substituted 8-[6-amino-3-pyridyl]xanthines](/docs/US/2011-02-08/US07884100B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 8-[6-amino-3-pyridyl]xanthines
- Patent Title (中): 取代的8- [6-氨基-3-吡啶基]黄嘌呤
-
Application No.: US11811823Application Date: 2007-06-12
-
Publication No.: US07884100B2Publication Date: 2011-02-08
- Inventor: Guoquan Wang , Robert D. Thompson , Jayson M. Rieger
- Applicant: Guoquan Wang , Robert D. Thompson , Jayson M. Rieger
- Applicant Address: US MA Newton
- Assignee: PGxHealth, LLC
- Current Assignee: PGxHealth, LLC
- Current Assignee Address: US MA Newton
- Agency: McCarter & English, LLP
- Main IPC: C07D473/06
- IPC: C07D473/06 ; A61K31/522 ; A61P11/06 ; A61P27/02 ; C07D401/12
![Substituted 8-[6-amino-3-pyridyl]xanthines](/abs-image/US/2011/02/08/US07884100B2/abs.jpg.150x150.jpg)
Abstract:
The present invention provides substituted 8-[6-amino-3-pyridyl]xanthines like the compound shown in the following formula: and pharmaceutical compositions that are selective antagonists of A2B adenosine receptors (ARs). These compounds and compositions are useful as pharmaceutical agents.
Public/Granted literature
- US20080004292A1 Substituted 8-[6-amino-3-pyridyl]xanthines Public/Granted day:2008-01-03
Information query
